Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1993 1
1995 2
1996 5
1997 9
1998 8
1999 18
2000 17
2001 13
2002 9
2003 13
2004 8
2005 28
2006 19
2007 23
2008 32
2009 11
2010 26
2011 24
2012 26
2013 29
2014 17
2015 14
2016 24
2017 26
2018 11
2019 10
2020 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Results by year

Filters applied: . Clear all
Page 1
Adverse Effects of GLP-1 Receptor Agonists.
Filippatos TD, Panagiotopoulou TV, Elisaf MS. Filippatos TD, et al. Among authors: elisaf ms. Rev Diabet Stud. 2014 Fall-Winter;11(3-4):202-30. doi: 10.1900/RDS.2014.11.202. Epub 2015 Feb 10. Rev Diabet Stud. 2014. PMID: 26177483 Free PMC article. Review.
Hyponatremia in the elderly: challenges and solutions.
Filippatos TD, Makri A, Elisaf MS, Liamis G. Filippatos TD, et al. Among authors: elisaf ms. Clin Interv Aging. 2017 Nov 14;12:1957-1965. doi: 10.2147/CIA.S138535. eCollection 2017. Clin Interv Aging. 2017. PMID: 29180859 Free PMC article. Review.
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study.
Tromp TR, Hartgers ML, Hovingh GK, Vallejo-Vaz AJ, Ray KK, Soran H, Freiberger T, Bertolini S, Harada-Shiba M, Blom DJ, Raal FJ, Cuchel M; Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Tromp TR, et al. Lancet. 2022 Feb 19;399(10326):719-728. doi: 10.1016/S0140-6736(21)02001-8. Epub 2022 Jan 28. Lancet. 2022. PMID: 35101175 Free PMC article.
SGLT2 inhibitors: are they safe?
Filippas-Ntekouan S, Filippatos TD, Elisaf MS. Filippas-Ntekouan S, et al. Among authors: elisaf ms. Postgrad Med. 2018 Jan;130(1):72-82. doi: 10.1080/00325481.2018.1394152. Epub 2017 Oct 27. Postgrad Med. 2018. PMID: 29039237 Review.
Statin myopathy: navigating the maze.
Rizos CV, Elisaf MS. Rizos CV, et al. Among authors: elisaf ms. Curr Med Res Opin. 2017 Feb;33(2):327-329. doi: 10.1080/03007995.2016.1255601. Epub 2016 Nov 11. Curr Med Res Opin. 2017. PMID: 27805428 No abstract available.
Pharmacological management of diabetic dyslipidemia.
Filippatos TD, Florentin M, Georgoula M, Elisaf MS. Filippatos TD, et al. Among authors: elisaf ms. Expert Rev Clin Pharmacol. 2017 Feb;10(2):187-200. doi: 10.1080/17512433.2017.1263565. Epub 2016 Dec 2. Expert Rev Clin Pharmacol. 2017. PMID: 27868450 Review.
Emerging Fixed-Dose Combination Treatments for Hyperlipidemia.
Pappa E, Rizos CV, Filippatos TD, Elisaf MS. Pappa E, et al. Among authors: elisaf ms. J Cardiovasc Pharmacol Ther. 2019 Jul;24(4):315-322. doi: 10.1177/1074248419838506. Epub 2019 Mar 25. J Cardiovasc Pharmacol Ther. 2019. PMID: 30909733 Review.
385 results